Concepedia

Julien Fourcade

JF

14

Publications

3.4K

Citations

13

H-Index

2004

Active since

Affiliations

University of Pittsburgh(Current)

University of Lausanne

Ludwig Cancer Research

Brigham and Women's Hospital

Bristol-Myers Squibb (United States)

Julien Fourcade is an author at University of Pittsburgh specializing in tumor immunity, medicine, and immunology.

Top concepts

MedicineImmunologyImmunotherapyTumor ImmunityAutoimmunityCell BiologyImmuno-oncologyImmunodominanceT Cell ImmunityImmune Regulation

Publications per year

2004–2018

14

Publications

14

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

Julien Fourcade, Zhaojun Sun, Mourad Benallaoua et al. · The Journal of Experimental Medicine · 2010 · 1.3K citations · Full text

TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

Joë-Marc Chauvin, Ornella Pagliano, Julien Fourcade et al. · Journal of Clinical Investigation · 2015 · 751 citations · Full text

Immunology, Immune Regulation, Immunodominance +23

CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

Julien Fourcade, Zhaojun Sun, Ornella Pagliano et al. · Cancer Research · 2011 · 362 citations · Full text

Inhibitory Receptors Btla, T-regulatory Cell, Immunology +25

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines

Julien Fourcade, Zhaojun Sun, Ornella Pagliano et al. · Cancer Research · 2013 · 204 citations · Full text

Class Ii, Immune Regulation, Immunology +26

CD226 opposes TIGIT to disrupt Tregs in melanoma

Julien Fourcade, Zhaojun Sun, Joë-Marc Chauvin et al. · JCI Insight · 2018 · 195 citations · Full text

T-regulatory Cell, Immune Regulation, Immunology +16

Rows per page

1–5 of 14